Results for tag: "Neurotrophic Keratitis Drug"

Neurotrophic Keratitis (NK) is a rare, degenerative eye disorder that affects the cornea, the clear outer layer of the eye. It is caused by a lack of nerve supply to the cornea, resulting in decreased tear production and corneal thinning. NK is treated with a variety of drugs, including topical corticosteroids, antibiotics, and immunomodulators. These drugs are used to reduce inflammation, improve tear production, and protect the cornea from further damage. Optical Disorders Drugs are a class of drugs used to treat a variety of eye diseases, including NK. These drugs are designed to reduce inflammation, improve tear production, and protect the cornea from further damage. They are typically administered topically, either as eye drops or ointments. Some companies in the Neurotrophic Keratitis Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, and Shire. Show Less Read more